Compare $EGRX vs $SYBX | Chartloom

Compare

$EGRX vs $SYBX

Eagle Pharmaceuticals Inc · Synlogic Inc

EGRX

Eagle Pharmaceuticals Inc

SYBX

Synlogic Inc

Compare $EGRX vs $SYBX

Comparing Eagle Pharmaceuticals Inc and Synlogic Inc

EGRXEagle Pharmaceuticals Inc

SYBXSynlogic Inc

EGRXEagle Pharmaceuticals Inc

Market cap

$13M

P/E (TTM)

1.06x

Forward P/E (NTM)

0.25x

Forward P/S (NTM)

0.05x

Rev growth (TTM)

-5.4%

YTD performance

185.3%

52W performance

49.2%

FCF yield

-74.5%

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EGRX

SYBX

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

SYBX

Synlogic Inc

Market Cap

EGRX$13M

SYBX$13M

Enterprise Value

EGRX$67M

SYBX$292K

Price

EGRX$0.97

SYBX$1.10

P/E Ratio

EGRX1.06x

SYBXN/A

P/S Ratio

EGRX0.05x

SYBX4.20x

EV/Sales

EGRX0.26x

SYBX0.09x

EV/EBITDA

EGRX1.07x

SYBX0.00x

P/B Ratio

EGRX0.05x

SYBX1.12x

P/FCF Ratio

EGRXN/A

SYBXN/A

EV/FCF

EGRX-7.18x

SYBX-0.08x

PEG Ratio

EGRXN/A

SYBXN/A

Forward P/E (NTM)

EGRX0.25x

SYBXN/A

Forward P/S (NTM)

EGRX0.05x

SYBXN/A

Revenue (TTM)

EGRX$258M

SYBX$0

Revenue Growth (YoY)

EGRX-5.4%

SYBXN/A

Forward Rev Growth

EGRX0.0%

SYBX0.0%

Gross Margin (TTM)

EGRX69.9%

SYBX0.0%

Operating Margin (TTM)

EGRX14.0%

SYBX0.0%

EBITDA Margin (TTM)

EGRX24.5%

SYBX0.0%

Net Margin (TTM)

EGRX4.7%

SYBX0.0%

FCF Margin (TTM)

EGRX-3.6%

SYBXN/A

Net Income (TTM)

EGRX$12M

SYBX$-655K

FCF (TTM)

EGRX$-9M

SYBX$-4M

EPS (TTM)

EGRX$0.92

SYBX-$0.05

ROE (TTM)

EGRX5.0%

SYBX-560.0%

ROA (TTM)

EGRX3.0%

SYBX-436.0%

ROIC (TTM)

EGRX3.9%

SYBX-560.0%

Cash

EGRX$15M

SYBX$13M

Debt

EGRX$70M

SYBX$0

Net Cash/Debt

EGRX$-55M

SYBX$13M

Current Ratio (TTM)

EGRX2.16x

SYBX9.19x

Quick Ratio (TTM)

EGRX1.52x

SYBX9.05x

Debt/Equity (TTM)

EGRX0.28x

SYBX0.00x

Debt/Assets (TTM)

EGRX0.0%

SYBX0.0%

Interest Coverage (TTM)

EGRXN/A

SYBXN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

SYBX0.00x

Beta

EGRX0.88

SYBX0.87

52W Performance

EGRX49.2%

SYBX-24.7%

YTD Performance

EGRX185.3%

SYBX-6.0%

% from 52W High

EGRX-74.9%

SYBX-41.2%

% from 52W Low

EGRX88081.8%

SYBX103.7%

Asset Turnover (TTM)

EGRX0.64x

SYBX0.05x

FCF Yield (TTM)

EGRX-74.5%

SYBX-28.5%

Earnings Yield (TTM)

EGRX96.0%

SYBX-4.9%

Dividend Yield (TTM)

EGRXN/A

SYBXN/A

Rule of 40

EGRX-9.0

SYBX0.0

EV/GP/RG

EGRXN/A

SYBXN/A

Ticker research

View EGRX research View SYBX research

Metric	EGRX Eagle Pharmaceuticals Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$13M	$13M
Enterprise Value	$67M	$292K
Price	$0.97	$1.10
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	4.20x
EV/Sales	0.26x	0.09x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$0
Revenue Growth (YoY)	-5.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	0.0%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	0.0%
Net Margin (TTM)	4.7%	0.0%
FCF Margin (TTM)	-3.6%	N/A
Net Income (TTM)	$12M	$-655K
FCF (TTM)	$-9M	$-4M
EPS (TTM)	$0.92	-$0.05
ROE (TTM)	5.0%	-560.0%
ROA (TTM)	3.0%	-436.0%
ROIC (TTM)	3.9%	-560.0%
Financial Health
Cash	$15M	$13M
Debt	$70M	$0
Net Cash/Debt	$-55M	$13M
Current Ratio (TTM)	2.16x	9.19x
Quick Ratio (TTM)	1.52x	9.05x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.87
52W Performance	49.2%	-24.7%
YTD Performance	185.3%	-6.0%
% from 52W High	-74.9%	-41.2%
% from 52W Low	88081.8%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.05x
FCF Yield (TTM)	-74.5%	-28.5%
Earnings Yield (TTM)	96.0%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View SYBX research

Valuation

P/E Ratio

EGRX

1.06x

P/S Ratio

EGRX

0.05x

SYBX

4.20x

EV/FCF

EGRX

-7.18x

SYBX

-0.08x

Growth & revenue

Revenue Growth TTM

EGRX

-5.4%

Forward Revenue Growth

EGRX

0.0%

SYBX

0.0%

Profitability & performance

Gross Margin

EGRX

69.9%

SYBX

0.0%

ROE

EGRX

5.0%

SYBX

-560.0%

FCF Yield %

SYBX

-28.5%

EGRX

-74.5%

52-Week Performance

EGRX

49.2%

SYBX

-24.7%

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

SYBX

Synlogic Inc

Market Cap

EGRX$13M

SYBX$13M

Enterprise Value

EGRX$67M

SYBX$292K

Price

EGRX$0.97

SYBX$1.10

P/E Ratio

EGRX1.06x

SYBXN/A

P/S Ratio

EGRX0.05x

SYBX4.20x

EV/Sales

EGRX0.26x

SYBX0.09x

EV/EBITDA

EGRX1.07x

SYBX0.00x

P/B Ratio

EGRX0.05x

SYBX1.12x

P/FCF Ratio

EGRXN/A

SYBXN/A

EV/FCF

EGRX-7.18x

SYBX-0.08x

PEG Ratio

EGRXN/A

SYBXN/A

Forward P/E (NTM)

EGRX0.25x

SYBXN/A

Forward P/S (NTM)

EGRX0.05x

SYBXN/A

Revenue (TTM)

EGRX$258M

SYBX$0

Revenue Growth (YoY)

EGRX-5.4%

SYBXN/A

Forward Rev Growth

EGRX0.0%

SYBX0.0%

Gross Margin (TTM)

EGRX69.9%

SYBX0.0%

Operating Margin (TTM)

EGRX14.0%

SYBX0.0%

EBITDA Margin (TTM)

EGRX24.5%

SYBX0.0%

Net Margin (TTM)

EGRX4.7%

SYBX0.0%

FCF Margin (TTM)

EGRX-3.6%

SYBXN/A

Net Income (TTM)

EGRX$12M

SYBX$-655K

FCF (TTM)

EGRX$-9M

SYBX$-4M

EPS (TTM)

EGRX$0.92

SYBX-$0.05

ROE (TTM)

EGRX5.0%

SYBX-560.0%

ROA (TTM)

EGRX3.0%

SYBX-436.0%

ROIC (TTM)

EGRX3.9%

SYBX-560.0%

Cash

EGRX$15M

SYBX$13M

Debt

EGRX$70M

SYBX$0

Net Cash/Debt

EGRX$-55M

SYBX$13M

Current Ratio (TTM)

EGRX2.16x

SYBX9.19x

Quick Ratio (TTM)

EGRX1.52x

SYBX9.05x

Debt/Equity (TTM)

EGRX0.28x

SYBX0.00x

Debt/Assets (TTM)

EGRX0.0%

SYBX0.0%

Interest Coverage (TTM)

EGRXN/A

SYBXN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

SYBX0.00x

Beta

EGRX0.88

SYBX0.87

52W Performance

EGRX49.2%

SYBX-24.7%

YTD Performance

EGRX185.3%

SYBX-6.0%

% from 52W High

EGRX-74.9%

SYBX-41.2%

% from 52W Low

EGRX88081.8%

SYBX103.7%

Asset Turnover (TTM)

EGRX0.64x

SYBX0.05x

FCF Yield (TTM)

EGRX-74.5%

SYBX-28.5%

Earnings Yield (TTM)

EGRX96.0%

SYBX-4.9%

Dividend Yield (TTM)

EGRXN/A

SYBXN/A

Rule of 40

EGRX-9.0

SYBX0.0

EV/GP/RG

EGRXN/A

SYBXN/A

Ticker research

View EGRX research View SYBX research

Metric	EGRX Eagle Pharmaceuticals Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$13M	$13M
Enterprise Value	$67M	$292K
Price	$0.97	$1.10
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	4.20x
EV/Sales	0.26x	0.09x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$0
Revenue Growth (YoY)	-5.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	0.0%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	0.0%
Net Margin (TTM)	4.7%	0.0%
FCF Margin (TTM)	-3.6%	N/A
Net Income (TTM)	$12M	$-655K
FCF (TTM)	$-9M	$-4M
EPS (TTM)	$0.92	-$0.05
ROE (TTM)	5.0%	-560.0%
ROA (TTM)	3.0%	-436.0%
ROIC (TTM)	3.9%	-560.0%
Financial Health
Cash	$15M	$13M
Debt	$70M	$0
Net Cash/Debt	$-55M	$13M
Current Ratio (TTM)	2.16x	9.19x
Quick Ratio (TTM)	1.52x	9.05x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.87
52W Performance	49.2%	-24.7%
YTD Performance	185.3%	-6.0%
% from 52W High	-74.9%	-41.2%
% from 52W Low	88081.8%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.05x
FCF Yield (TTM)	-74.5%	-28.5%
Earnings Yield (TTM)	96.0%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View SYBX research